19
Views
7
CrossRef citations to date
0
Altmetric
Review

Cancer chemotherapeutics - angiogenesis agents: October 1999 - March 2000

Pages 767-786 | Published online: 25 Feb 2005
 

Abstract

Angiogenesis is often defined as the formation of capillary blood vessels from existing blood vessels. In the area of cancer research, approaches that seek to block angiogenesis are under intense investigation. In the past six months, a number of applications have appeared referring to small molecule inhibitors of matrix metalloproteinases (MMPs), the VEGF receptor tyrosine kinase, the integrin receptor αvβ3 and other defined targets. This review summarises the key features of these applications as well as other disclosures involving natural products claimed as angiogenesis inhibitors. The review also summarises angiogenesis-related disclosures involving endogenous inhibitors, novel targets and interesting technologies that have appeared in applications published between October 1999 and March 2000. If the patent activity is any indication, there is significant interest and a number of opportunities for treating cancer through inhibiting angiogenesis.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.